ALNY vs UTZ · P/E 76, rev $1.29B vs P/E 40, rev $733.1M
Alnylam Pharmaceuticals Inc (ALNY) versus Utz Brands Inc (UTZ) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Utz Brands Inc (UTZ) is a packaged foods company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported UTZ revenue for 2026-06-28 was $733.1M. Net income was -$11.8M. UTZ currently screens at market cap $1.13B and trailing P/E 39.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. UTZ currently screens at market cap $1.13B and trailing P/E 39.9.
Not investment advice. Open the ALNY and UTZ stock pages for the full models.
Not investment advice.